Establishing a combined stimulation protocol hFSH followed by rFSH might represent a breakthrough in the IVF practice

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 15, 2013, Pages 2091-2096

  Gerli, S ^a   Di Renzo, G C ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Follicle stimulating hormone; Gonadotropin; IVF

Indexed keywords

RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MALE; MENSTRUAL CYCLE; OOCYTE DEVELOPMENT; OOCYTE MATURATION; OOCYTE RETRIEVAL; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL;

EID: 84884216514     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. LOUMAYE E, CAMPBELL R, SALAT-BAROUX J. Human follicle- stimulating hormone produced by recombinant DNA technology: a review for clinicians. Hum Reprod Update 1995; 1: 188-199.
2. OLIJVE W, DE BOER W, MULDERS JW, VAN WEZENBEEK PM. Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon). Mol Hum Reprod 1996; 2: 371-382. (Pubitemid 126717452)
3. OUT HJ, MANNAERTS BM, DRIESSEN SG, COELINGH BENNINK HJ. Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies.Hum Reprod Update 1996; 2: 162-171. (Pubitemid 26173042)
4. OUT HJ, MANNAERTS BM, DRIESSEN SG, BENNINK HJ. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in invitro fertilization.Hum Reprod 1995; 10: 2534-2540.
5. BERGH C, HOWLES CM, BORG K, HAMBERGER L, JOSEFSSON B, NILSSON L, WIKLAND M. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 1997; 12: 2133-2139. (Pubitemid 27494016)
6. DEVROEY P, MANNAERTS B, SMITZ J, COELINGH BENNINK H, VAN STEIRTEGHEM A. Clinical outcome of a pilot efficacy study on recombinant human follicle- stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens. Hum Reprod 1994; 9: 1064-1069. (Pubitemid 24203895)
7. HEDON B, OUT HJ, HUGUES JN, CAMIER B, COHEN J, LOPES P, ZORN JR, VAN DER HEIJDEN B, COELINGH BENNINK HJ. Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized, assessor-blind, multicentre trial. Hum Reprod 1995; 10: 3102-3106. (Pubitemid 26026503)
8. OUT HJ, REIMITZ PE, BENNINK HJ. A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon). Fertil Steril 1997; 67: 278-283. (Pubitemid 27052185)
9. JANSEN CA, VAN OS HC, OUT HJ, COELINGH BENNINK HJ. A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients. Hum Reprod 1998; 13: 2995-2999. (Pubitemid 28521838)
10. GERLI S, BINI V, FAVILLI A, DI RENZO GC. Clinical efficacy and cost-effectiveness of HP-human FSH (Fostimon®) versus rFSH (Gonal-F®) in IVF-ICSI cycles: a meta-analysis. Gynecol Endocrinol 2013; 29: 520-529.
11. NG EH, LAU EY, YEUNG WS, HO PC. HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial. Hum Reprod 2001; 16: 319-325. (Pubitemid 32149428)
12. STREHLER E, ABT M, EL-DANASOURI I, DE SANTO M, STERZIK K. Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome. Fertil Steril 2001; 75: 332-336. (Pubitemid 32112110)
13. SELMAN HA, DE SANTO M, STERZIK K, COCCIA E, ELDANASOURI I. Effect of highly purified urinary follicle- stimulating hormone on oocyte and embryo quality. Fertil Steril 2002; 78: 1061-1067. (Pubitemid 35292509)
14. WEST CR, CARLSON NE, LEE JS, MCNEILLY AS, SHARMA TP, YE W, PADMANABHAN V. Acidic mix of FSH isoforms are better facilitators of ovarian follicular maturation and E2 production than the less acidic. Endocrinology 2002; 143: 107-116. (Pubitemid 34056409)
15. D'ANTONIO M, BORRELLI F, DATOLA A, BUCCI R, MASCIA M, POLLETTA P, PISCITELLI D, PAPOIAN R. Biological characterization of recombinant human follicle stimulating hormone isoforms. Hum Reprod 1999; 14: 1160-1167. (Pubitemid 29224883)
16. VITT UA, KLOOSTERBOER HJ, ROSE UM, MULDERS JW, KIESEL PS, BETE S, NAYUDU PL. Isoforms of human recombinant follicle-stimulating hormone: comparison of effects on murine follicle development in vitro. Biol Reprod 1998; 59: 854-861. (Pubitemid 28463337)
17. PADMANABHAN V, SAIRAM MR, HASSING JM, BROWN MB, RIDINGS JW, BEITINS IZ. Follicle-stimulating hormone signal transduction: role of carbohydrate in aromatase induction in immature rat Sertoli cells. Mol Cell Endocrinol 1991; 79: 119-128.
18. WIDE L. Follicle-stimulating hormones in anterior pituitary glands from children and adults differ in relation to sex and age. J Endocrinol 1989; 123: 519-529. (Pubitemid 20001481)
19. WIDE L, BAKOS O. More basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase. J Clin Endocrinol Metabol 1993; 76: 885-889. (Pubitemid 23110832)
20. PHILLIPS DJ, WIDE L. Serum gonadotropin isoforms become more basic after an exogenous challenge of gonadotropin-releasing hormone in children undergoing pubertal development. J Clin Endocrinol Metab 1994; 79: 814-819. (Pubitemid 24286408)
21. ZAMBRANO E, BARRIOS-DE-TOMASI J, CARDENAS M, ULLOA- AGUIRRE A. Studies on the relative in-vitro biological potency of the naturally-occurring isoforms of intrapituitary follicle stimulating hormone. Mol Hum Reprod 1996; 2: 563-571. (Pubitemid 126720776)
22. ULLOA-AGUIRRE A, DAMIAN-MATSUMURA P, JIMENEZ M, ZAMBRANO E, DIAZ-SANCHEZ V. Biological characterization of the isoforms of urinary human follicle-stimulating hormone contained in a purified commercial preparation. Hum Reprod 1992; 7: 1371-1378. (Pubitemid 23042156)
23. VEECK LL. An atlas of human gametes and conception. London. Parthenon; 1999.
24. VEECK LL. Oocyte assessment and biological performance. Ann N Y Acad Sci 1988; 541: 259-274. (Pubitemid 19025506)
25. HILD-PETITO S, STOUFFER RL, BRENNER RM. Immunocytochemical localization of estradiol and progesterone receptors in the monkey ovary throughout the menstrual cycle. Endocrinology 1988; 123: 2896-2905. (Pubitemid 19012809)
26. ZELINSKI-WOOTEN MB, HESS DL, WOLF DP, STOUFFER RL. Steroid reduction during ovarian stimulation impairs oocyte fertilization, but not folliculogenesis, in rhesus monkeys. Fertil Steril 1994; 61: 1147-1155. (Pubitemid 24166437)
27. WU TC, WANG L, WAN YJ. Detection of estrogen receptor messenger ribonucleic acid in human oocytes and cumulus-oocyte complexes using reverse transcriptase-polymerase chain reaction. Fertil Steril 1993; 59: 54-59. (Pubitemid 23027335)
28. TESARIK J, MENDOZA C. Direct non-genomic effects of follicular steroids on maturing human oocytes: oestrogen versus androgen antagonism. Hum Reprod Update 1997; 3: 95-100. (Pubitemid 27389981)
29. TESARIK J, MENDOZA C. Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab 1995; 80: 1438-1443.
30. LOUMAYE E, ENGRAND P, HOWLES CM, O'DEA L. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril 1997; 67: 889-899. (Pubitemid 27195030)
31. WESTERGAARD LG, LAURSEN SB, ANDERSEN CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 2000; 15: 1003-1008. (Pubitemid 30251290)
32. FLEMING R, LLOYD F, HERBERT M, FENWICK J, GRIFFITHS T, MURDOCH A. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod 1998; 13: 1788-1792.
33. FLEMING R, REHKA P, DESHPANDE N, JAMIESON ME, YATES RW, LYALL H. Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH. Hum Reprod 2000; 15: 1440-1445.
34. ESPOSITO MA, BARNHART KT, COUTIFARIS C, PATRIZIO Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertil Steril 2001; 75: 519-524. (Pubitemid 32175666)
35. SAIRAM MR, BHARGAVI GN. A role for glycosylation of the alpha subunit in transduction of biological signal in glycoprotein hormones.Science 1985; 229: 65-67. (Pubitemid 15018281)
36. BISHOP LA, ROBERTSON DM, CAHIR N, SCHOFIELD PR. Specific roles for the asparagine-linked carbohydrate residues of recombinant human follicle stimulating hormone in receptor binding and signal transduction. Mol Endocrinol 1994; 8: 722-731. (Pubitemid 24179664)
37. DAVIS D, LIU X, SEGALOFF DL. Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function. Mol Endocrinol 1995; 9: 159-170.
38. CHAPPEL SC, ULLOA-AGUIRRE A, RAMALEY JA. Sexual maturation in female rats: time-related changes in the isoelectric focusing pattern of anterior pituitary follicle-stimulating hormone. Biol Reprod 1983; 28: 196-205. (Pubitemid 13130542)
39. BLUM WF, GUPTA D. Heterogeneity of rat FSH by chromatofocusing: studies on serum FSH, hormone released in vitro and metabolic clearance rates of its various forms. J Endocrinol 1985; 105: 29-37. (Pubitemid 15119550)
40. WIDE L. The regulation of metabolic clearance rate of human FSH in mice by variation of the molecular structure of the hormone. Acta Endocrinol 1986; 112: 336-344. (Pubitemid 16061983)
41. WIDE L, HOBSON B. Influence of the assay method used on the selection of the most active forms of FSH from the human pituitary. Acta Endocrinol 1986; 113: 17-22. (Pubitemid 16018982)
42. FLACK MR, BENNET AP, FROEHLICH J, ANASTI JN, NISULA BC. Increased biological activity due to basic isoforms in recombinant human follicle-stimulating hormone produced in a human cell line. J Clin Endocrinol Metab 1994; 79: 756-760. (Pubitemid 24286398)
43. GALWAY AB, HSUEH AJ, KEENE JL, YAMOTO M, FAUSER BC, BOIME I. In vitro and in vivo bioactivity of recombinant human follicle-stimulating hormone and partially deglycosylated variants secreted by transfected eukaryotic cell lines. Endocrinology 1990; 127: 93-100. (Pubitemid 20228106)
44. ZAMBRANO E, OLIVARES A, MENDEZ JP, GUERRERO L, DIAZ- CUETO L, VELDHUIS JD, ULLOA-AGUIRRE A. Dynamics of basal and gonadotropin-releasing hormonereleasable serum follicle-stimulating hormone charge isoform distribution throughout the human menstrual cycle. J Clin Endocrinol Metab 1995; 80: 1647-1656.
45. PADMANABHAN V, LANG LL, SONSTEIN J, KELCH RP, BEITINS IZ. Modulation of serum follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal ysgenesis. J Clin Endocrinol Metab 1988; 67: 465-473.